GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Sale Of Investment

Pangen Biotech (XKRX:222110) Sale Of Investment : ₩163 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Sale Of Investment?

Pangen Biotech's sale of investment for the three months ended in Mar. 2024 was ₩163 Mil. It means Pangen Biotech gained ₩163 Mil from selling investments. Pangen Biotech's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ₩163 Mil.

Compared with last quarter (₩0 Mil in Dec. 2023 ), Pangen Biotech gained more money from selling investments in Mar. 2024 (₩163 Mil).


Pangen Biotech Sale Of Investment Historical Data

The historical data trend for Pangen Biotech's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangen Biotech Sale Of Investment Chart

Pangen Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43,000.00 65,298.39 35,550.00 35,550.00 4,063.00

Pangen Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 163.00

Pangen Biotech Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩163 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pangen Biotech Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Pangen Biotech's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Pangen Biotech (XKRX:222110) Business Description

Traded in Other Exchanges
N/A
Address
4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Pangen Biotech (XKRX:222110) Headlines

No Headlines